Corbus Pharmaceuticals (NASDAQ:CRBP) reported its Q4 earnings results on Tuesday, March 12, 2024 at 08:00 AM. Here’s what investors need to know about the announcement. EarningsCorbus Pharmaceuticals beat estimated earnings by 23.0%, reporting an EPS of $-1.81 versus an estimate of $-2.36. Revenue was down $0 from the same period last year. Past Earnings PerformanceLast quarter the company missed on EPS by $0.21 which was followed by a 9.0% drop in the share price the next day. To track all earnings releases for Corbus Pharmaceuticals visit their earnings calendar here. This article was genera…